ArticleArchives of public health = Archives belges de sante publique2025
Primary, secondary and tertiary prevention of long-term benzodiazepine receptor agonists use in Belgium: a policy Delphi.
Article in Archives of public health = Archives belges de sante publique, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe long-term use of benzodiazepine receptor agonists (BZRAs) poses a significant public health challenge in Belgium because of the associated risks of physical and psychological dependence. Despite guidelines recommending short-term use, BZRAs are frequently prescribed beyond the recommended duration, leading to chronic use and associated harm. To address this issue, a policy Delphi study was conducted to assess targeted strategies for preventing long-term BZRA use through the lenses of primary, secondary, and tertiary prevention.
methodsThe study involved a panel of experts, including healthcare professionals and patients, who participated in two rounds of questionnaires to evaluate 27 policy recommendations. These recommendations were assessed for feasibility, support, and importance, and participants were also asked whether the necessary conditions were in place to implement each recommendation. This approach aimed to identify areas of consensus and divergence among participants.
resultsKey findings reveal a strong consensus on the need for awareness campaigns aimed at healthcare professionals and the general public to highlight the risks associated with BZRA withdrawal. There was also significant support for implementing training programs to equip healthcare providers with the skills needed to manage BZRA withdrawal effectively. However, some recommendations, such as increasing remuneration for long follow-up consultations and establishing a peer support "benzo-buddy" system, garnered less agreement, suggesting that these proposals require further refinement.
conclusionThis study highlights the complexity of addressing long-term BZRA use and advocates for a comprehensive, multifaceted approach. This approach should integrate education, awareness, and tailored healthcare practices to increase prevention efforts. The findings emphasise the importance of coordinated interventions across different levels of prevention to effectively mitigate long-term use on BZRAs in Belgium. By refining and implementing these strategies, the likelihood of achieving meaningful improvements in the management and reduction of chronic BZRA use could be significantly increased, contributing to better public health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.